Showing results (331-340 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|October 30, 2013
Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011Simon A Handley, Sally V J Bowskill, Maxine X Patel, et al.Therapeutic Advances in Psychopharmacology|October 30, 2013
Sleep architecture in ziprasidone-treated bipolar depression: a pilot studyAnusha Baskaran, Dave Summers, Stephanie Lm Willing, et al.Therapeutic Advances in Psychopharmacology|October 30, 2013
A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseDavid Taylor, Alan Lenox-Smith, Andrew BradleyTherapeutic Advances in Psychopharmacology|October 30, 2013
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature reviewKyoko Higashi, Goran Medic, Kavi J Littlewood, et al.Therapeutic Advances in Psychopharmacology|October 30, 2013
Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problemW Victor R Vieweg, Mehrul Hasnain, Robert H Howland, et al.Therapeutic Advances in Psychopharmacology|February 26, 2016
Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reportsMemduha Aydin, Bilge Cetin Ilhan, Saliha Calisir, et al.Therapeutic Advances in Psychopharmacology|August 25, 2015
Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case seriesCana Aksoy Poyraz, Şenol Turan, Ömer Faruk Demirel, et al.Therapeutic Advances in Psychopharmacology|July 26, 2017
Long-term use of benzodiazepines in older patients in Germany: a retrospective analysisLouis Jacob, Michael A Rapp, Karel KostevTherapeutic Advances in Psychopharmacology|May 4, 2016
Effectiveness of long-acting antipsychotics in clinical practice: 2. Effects of antipsychotic polypharmacy on risperidone long-acting injection and zuclopenthixol decanoateMatthew Cordiner, Polash Shajahan, Sarah McAvoy, et al.Therapeutic Advances in Psychopharmacology|May 4, 2016
Multiple D2 heteroreceptor complexes: new targets for treatment of schizophreniaDasiel O Borroto-Escuela, Julia Pintsuk, Thorsten Schäfer, et al.Pageof 55